share_log
Reuters ·  Aug 5 09:09
Alzamend Neuro Partners With Massachusetts General Hospital for a Phase II Clinical Trial of Al001, a Next-Generation Lithium Therapeutic Drug Candidate, Involving Patients With Alzheimer’s Disease
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment